FDX1 and neoplasm: The dual‐targeting MIL‐Cu1.8S‐TPP/FA nanoplatform effectively delivered copper ions to mitochondria and iron ions to tumor cells, modulating key ferroptosis‐ and cuproptosis‐related markers, such as GPX4, GSH, FDX‐1, and HSP70.